Middle East & Africa Carrier Testing Services Market Size and Forecast (2021 - 2031)

The Middle East & Africa Carrier Testing Services Market is projected to grow significantly, reaching an estimated US$ 38.5 million by 2031, up from US$ 16.1 million in 2024. This growth reflects a compound annual growth rate (CAGR) of 13.5% from 2025 to 2031, indicating a robust demand for carrier testing services in the region.

Executive Summary and Market Analysis

The carrier testing services market in the Middle East and Africa is primarily segmented into key regions: the UAE, Saudi Arabia, South Africa, and the Rest of MEA. A notable factor driving the demand for carrier screening in Middle Eastern countries is the prevalence of consanguineous marriages, which increases the risk of recessive genetic disorders. As a result, there is a heightened need for genetic screening to identify potential hereditary conditions.

Several countries in the region are at various stages of implementing or enhancing national or premarital genetic screening programs, reflecting governmental commitment to mitigating the impact of hereditary diseases. On the technological front, genetic testing laboratories and companies are expanding their capabilities and forming partnerships with local healthcare providers. Despite challenges such as inadequate infrastructure and a shortage of genetic counseling in parts of Africa, some nations are making strides toward establishing better diagnostic networks and training more genetic counselors through targeted investments.

The adoption of next-generation sequencing (NGS) technologies and the availability of more affordable testing options are broadening access to genetic testing for a wider population. This presents a dual challenge for carriers and testing companies: they must navigate public health initiatives while also catering to the demands of private, often affluent, patient segments. Success in this market requires a deep understanding of local cultures, regulatory environments, and cost structures. Companies that forge local partnerships and customize their services to meet regional needs stand to gain significant long-term benefits.

Strategic Insights

# Market Segmentation Analysis

The Middle East & Africa Carrier Testing Services Market can be segmented by type, medical conditions, and end users:

• By Type: The market is divided into Expanded Carrier Screening and Targeted Disease Carrier Screening. The Expanded Carrier Screening segment is expected to dominate the market in 2024.
• By Medical Conditions: The market is categorized into Pulmonary Conditions, Hematological Conditions, Neurological Conditions, and Other Medical Conditions, with Pulmonary Conditions leading the market in 2024.
• By End User: The market is segmented into Hospital-Based Laboratories, Diagnostic Laboratories, and Other End Users, where Hospital-Based Laboratories are anticipated to hold the largest share in 2024.

Market Outlook

Supportive government policies and regulatory frameworks, particularly in the form of national screening programs, are crucial in reducing the prevalence of hereditary diseases. Several countries have initiated mandatory premarital genetic screening to identify carriers of severe recessive conditions before couples conceive. For instance, starting January 2025, the health authority in Abu Dhabi will require Emirati couples to undergo genetic testing for over 570 genes associated with more than 840 autosomal recessive diseases. Similarly, Saudi Arabia has long advocated for premarital screening for hemoglobinopathies, such as sickle cell anemia and beta-thalassemia, with programs available in over 130 healthcare centers.

Governments are not only investing in screening programs but also in building the necessary infrastructure. In the UAE, efforts are underway to enhance genetic counseling services, recognizing that the responsible communication of carrier test results must be conducted by trained specialists. This combination of policy mandates, public funding, and workforce development lays a strong foundation for scalable carrier testing services, positioning them as essential public health interventions.

Country Insights

The market is further segmented by country, with Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa being key players. The Rest of Middle East & Africa accounted for the largest market share in 2024, with countries like Bahrain, Kuwait, Oman, Qatar, Morocco, Algeria, Nigeria, Egypt, Tunisia, and Libya contributing significantly to the carrier testing services market.

Awareness of genetic disease risks is increasing, particularly in regions where consanguineous marriages are common. However, the infrastructure for genetic testing remains underdeveloped and fragmented across different regions. Regulatory frameworks vary widely; some areas have established policies for genetic counseling and screening, while others lack clear guidelines and sufficient capacity. To expand carrier screening panels, international genomics companies are actively seeking collaborations with local healthcare providers.

Organizations such as the Centre for Arab Genomic Studies (CAGS) and various academic and non-profit entities are leading efforts to document genetic disorders and facilitate research across the Arab world. The introduction of telemedicine and remote counseling services is also helping to extend access to genetic testing in areas with a shortage of genetic counselors. For businesses to succeed in this landscape, they must navigate regulatory differences, develop local expertise, and educate healthcare professionals and the public about the advantages of carrier screening.

Company Profiles

Key players in the Middle East & Africa Carrier Testing Services Market include F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Eurofins Scientific SE, Myriad Genetics Inc, Laboratory Corp of America Holdings, MedGenome Inc, Gene By Gene Ltd, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc, and Illumina, Inc. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase market share.